(2S,3R,4R,5S,6R)-2-[3-[[5-(4-Fluorophenyl)Thiophen-2-Yl]Methyl]-4-Methylphenyl]-6-(Hydroxymethyl)Oxane-3,4,5-Triol,Hydrate; Unii-0Sac974Z85; Canagliflozin Hydrate; Ta-7284; Invokan; Canagliflozin Hemihydrate Inn; Unii-0Sac974Z85

Brief Introduction

Kangliflozin hemihydrate is a kind of hydrate of kangliflozin. The chemical name of canagliflozin is 1-（ β- D-glucopyranosyl) - 4-methyl-3 - [5 - (4-fluorophenyl) - 2-thienylmethyl] benzene was developed by Johnson & Johnson's subsidiary, Janssen Pharmaceutical Company. Canglitazin is a chemical Book selective sodium glucose transporter type 2 (sglt-2) inhibitor, which can specifically inhibit the reabsorption of glucose by the kidney, so that excess glucose can be excreted from the urine, thus directly reducing the blood glucose level. The drug was approved by FDA in March 29, 2013 for the treatment of type II diabetes, the trade name is Invokana.

Sulfapiridazin Sodium

CAS:2577-32-4

Molecular Formula:C11H11N4NaO3S

Alias

More Information

Sodium Sulfapyridazine; Unii-Eq24M7728K; Sulfamethoxypyridazine Sodium Salt; Sodium;(4-Aminophenyl)Sulfonyl-(6-Methoxypyridazin-3-Yl)Azanide; Sodium 4-Amino-N-(6-Methoxypyridazin-3-Yl)-Benzenesulfonamide; Sodium ((4-Aminophenyl)Sulfonyl)(6-Methoxypyridazin-3-Yl)Amide; Sodium Sulfamethoxypyridazine; Sulfamethoxypyridazine Sodium; Sulfapyridazine Sodium; Sulfamethoxypyridazin Natrium; Sodium N-(6-Methoxypyridazin-3-Yl)Sulphanilamidate; Sulphamethoxypyridazine Sodium; Sodium, (N(Sup 1)-(6-Methoxy-3-Pyridazinyl)Sulfanilamido)-; Sale Sodico Della 2-P-Aminobenzensulfonamido-6-Metossipiridazina

Brief Introduction

This product is an anti infective drug.

Levocloperastine Fendizoate

CAS:220329-19-1

Molecular Formula:C40H38ClNO5

Alias

More Information

2-((6-Hydroxy(1,1'-Biphenyl)-3-Yl)Carbonyl)Benzoic Acid Compd. With 1-(2-((S)-(4-Chlorophenyl)Phenylmethoxy)Ethyl)Piperidine

Brief Introduction

This product is a pharmaceutical raw material and can be used for organic synthesis.

2-[3,5-Bis(Trifluoromethyl)Phenyl]-N,2-Dimethyl-N-[4-(2-Methylphenyl)-6-Morpholin-4-Ylpyridin-3-Yl]Propanamide

CAS:290296-68-3

Molecular Formula:C29H29F6N3O2

Alias

More Information

Unii-Rsh7Ndi7Mi; Befetupitant; Ro 67-5930; Rsh7Ndi7Mi

Brief Introduction

Befetupitant (Ro67-5930) is a drug developed by Hoffmann-La Roche which acts as a potent and selective antagonist for the NK1 receptor. It was originally developed as a potential antiemetic drug, though development was ultimately discontinued after a related drug netupitant was deemed to be more suitable for clinical development. Befetupitant has however continued to be researched for other possible applications such as treatment of corneal neovascularization.

Dihydroproscar

CAS:98319-24-5

Molecular Formula:C23H38N2O2

Alias

More Information

3-Oxo-4-Aza-5A-Androstane-17B-(N-Tert-Butylcarboxamide); (1S,3As,3Bs,5Ar,9Ar,9Bs,11As)-N-Tert-Butyl-9A,11A-Dimethyl-7-Oxo-1,2,3,3A,3B,4,5,5A,6,8,9,9B,10,11-Tetradecahydroindeno[5,4-F]Quinoline-1-Carboxamide; 3-Oxo-4-Aza-5-Alpha-Androstane-17-Beta-N-T-Butylcarboxamide; N-(1,1-Dimethyl)-3-Oxo-4-Aza-5A-Andro-Stane-17B-Carboxamide; 3-Oxo-4-Aza-5α-Androstane-17β-(N-T-Butylcarboxamide)

Brief Introduction

This product is a pharmaceutical intermediate and can be used in organic synthesis.

Inquiry (

/ 10

)

Clear All